Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-097180·CITADEL ADVISORS LLC
Schedule 13G ownership disclosure
Inspire Medical Systems Inc
Common Stock, par value $0.001 per share (the "Shares") · CUSIP: 457730109
Event date: 2025-09-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Citadel Advisors LLC
Shares: 1,379,861.00 · Class: 4.7%
- Citadel Advisors Holdings LP
Shares: 1,379,861.00 · Class: 4.7%
- Citadel GP LLC
Shares: 1,379,861.00 · Class: 4.7%
- Citadel Securities LLC
Shares: 114,245.00 · Class: 0.4%
- Citadel Securities Group LP
Shares: 333,181.00 · Class: 1.1%
- Citadel Securities GP LLC
Shares: 333,181.00 · Class: 1.1%
- Kenneth Griffin
Shares: 1,713,042.00 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-097180
- Form type
- SCHEDULE 13G
- Filer
- CITADEL ADVISORS LLC
- CIK
- CIK 1423053
- Filed
- Oct 06, 2025
- Reporting period
- Sep 29, 2025
- Description
- Schedule 13G beneficial ownership